|
[1]
|
Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Castaneda, J., et al. (2020) 2018 Updated European League against Rheumatism Evidence-Based Recommendations for the Diagnosis of Gout. Annals of the Rheumatic Diseases, 79, 31-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Dehlin, M., Jacobsson, L. and Roddy, E. (2020) Global Epidemiology of Gout: Prevalence, Incidence, Treatment Patterns and Risk Factors. Nature Reviews Rheumatology, 16, 380-390. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
林淑芃. 《中国高尿酸血症与痛风诊疗指南(2019)》解读[J]. 临床内科杂志, 2020, 37(6): 460-462.
|
|
[4]
|
柏李裕年, 焦洋. 难治性痛风的治疗[J]. 中华临床免疫和变态反应杂志, 2023, 17(4): 357-361.
|
|
[5]
|
Jatuworapruk, K. and Louthrenoo, W. (2023) Emerging Therapeutic Options for Refractory Gout. Nature Reviews Rheumatology, 20, 73-74. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
张欢, 甘建平, 吴斌. 难治性痛风1例的文献复习[J]. 中国现代医生, 2021, 59(1): 140-142+145.
|
|
[7]
|
Han, X., Yin, Y., Cao, Y., Chu, X., Han, Y., Di, H., et al. (2021) Rheumatologists’ Understanding of Refractory Gout: A Questionnaire Survey in China. Journal of International Medical Research, 49, 1-10. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Clore, J.N. and Thurby-Hay, L. (2009) Glucocorticoid-Induced Hyperglycemia. Endocrine Practice, 15, 469-474. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
罗文, 陈静. 糖皮质激素诱发骨质疏松研究进展[J]. 世界临床药物, 2024, 45(5): 464-469.
|
|
[10]
|
Miljic, P., Miljic, D., Cain, J.W., Korbonits, M. and Popovic, V. (2012) Pathogenesis of Vascular Complications in Cushing’s Syndrome. Hormones, 11, 21-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
张华东, 王梓淞, 王振兴, 等. 析“高梁之变”, 足生痛风[J]. 中国中医基础医学杂志, 2012, 18(10): 1075-1076.
|
|
[12]
|
徐润, 姜泉, 韩曼, 等. 从“阳化气, 阴成形”理论探讨姜泉教授治疗难治性痛风经验[J]. 中国医药导报, 2022, 19(24): 119-123.
|